Edition:
United States

ReShape Lifesciences Inc (RSLS.OQ)

RSLS.OQ on NASDAQ Stock Exchange Capital Market

1.33USD
14 Dec 2017
Change (% chg)

-- (--)
Prev Close
$1.33
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
130,350
52-wk High
$30.40
52-wk Low
$1.24

Chart for

About

ReShape Lifesciences Inc., formerly EnteroMedics Inc., is a medical device company. The Company is focused on the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders. The Company's neuroblocking technology, which is referred to as VBLOC... (more)

Overall

Beta: 2.99
Market Cap(Mil.): $29.54
Shares Outstanding(Mil.): 21.72
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 27.83 16.04
EPS (TTM): -- -- --
ROI: -- 10.00 34.69
ROE: -- 15.21 15.46

BRIEF-Reshape Lifesciences Inc - ‍Received Order For Reshape Integrated Dual Balloon System From Al Zahrawi ​

* RESHAPE LIFESCIENCES INC - ‍RECEIVED ORDER FOR RESHAPE INTEGRATED DUAL BALLOON SYSTEM FROM AL ZAHRAWI MEDICAL​ Source text for Eikon: Further company coverage: (Bangalore.newsroom@thomsonreuters.com)

Dec 13 2017

BRIEF-Reshape Lifesciences qtrly loss per share $1.06‍​

* Reshape Lifesciences announces third quarter 2017 financial results

Nov 14 2017

BRIEF-Enteromedics Inc says ‍has formally changed its name to Reshape Lifesciences Inc​

* Enteromedics Inc - ‍has formally changed its name to Reshape Lifesciences Inc​ Source text for Eikon: Further company coverage:

Oct 23 2017

Earnings vs. Estimates